Jefferies Financial Group Reiterates Hold Rating for Prestige Consumer Healthcare (NYSE:PBH)

Prestige Consumer Healthcare (NYSE:PBH – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Jefferies Financial Group in a note issued to investors on Tuesday, Benzinga reports. They presently have a $76.00 price objective on the stock, up from their prior price objective of $70.00. Jefferies Financial Group’s price objective would […]

Leave a Reply

Your email address will not be published.

Previous post PROCEPT BioRobotics (NASDAQ:PRCT) and Revolutions Medical (OTCMKTS:RMCP) Critical Analysis
Next post Funding Circle co-founder Samir Desai to leave board, marking end of an era